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Introduction: The NHS Long Term Plan (2019) acknowledges that children and young people with 
suspected autism wait too long for diagnostic assessment and sets out to reduce waiting times. 
However, diagnostic pathways vary with limited evidence on what model works best, for whom and 
in what circumstances. The National Autism Plan for Children (2003) recommended that assessment 
should be completed within 13 weeks but referral to diagnosis can take as long as 799 days.  
This Rapid Realist Review (RRR) is the first work package in a national programme of research:  a Realist 
Evaluation of Autism ServiCe Delivery (RE-ASCeD). We explore how particular approaches may deliver 
high quality and timely autism diagnostic services for children with possible autism; high quality is 
defined as compliant with NICE (2011) guidelines, and timely as a pathway lasting no more than one 
calendar year, based on previous work.  
Methods and analysis: RRR is a well-established approach to synthesising evidence within a 
compressed timeframe to identify models of service delivery leading to desired outcomes. RRR works 
backwards from intended outcomes, identified by NICE guidelines and the NHS England Long-Term 
Plan. The focus is a clearly defined intervention (the diagnostic pathway), associated with specific 
outcomes (high quality and timely), within a particular set of parameters (Autism and Child & 
Adolescent Mental Health services in the UK). Our Expert Stakeholder Group consists of policy makers, 
content experts and knowledge users with a wide range of experience to supplement, tailor and 
expedite the process. The RRR is consistent with RAMESES standards for realist syntheses and includes 
identifying the research question, searching for information, quality appraisal, data extraction, 
synthesising the evidence, validation of findings with experts and dissemination. 
Ethics and dissemination. Ethical approval not required. Findings will inform the wider RE-ASCeD 
evaluation and be reported to NHS England.  
 
Strengths of this study  
 This will be the first rapid realist review to synthesise evidence on the diagnostic pathway 
for children and adolescents with possible autism. 
 The review will address a major knowledge gap, using an established method, to explore 
how particular approaches may deliver high quality and timely autism diagnostic services for 
children with possible autism. 





The recently published NHS Long Term Plan,[1] acknowledges that children and young people with 
suspected autism wait too long for diagnostic assessment. The Plan set out an ambitious strategy to 
reduce waiting times while supporting children with autism (or other neurodevelopmental disorders) 
and their families, throughout the diagnostic process. However, there is much variation in the 
diagnostic pathway and limited evidence on what model works best, for whom and in what 
circumstances.  
Autism, also called Autistic Spectrum Disorder (ASD) or Condition, affects around 1-2% of children,[2-
5]. It is characterized by the presence of ‘persistent deficits in the ability to initiate and sustain 
reciprocal social interaction and social communication, and by a range of restricted, repetitive, 
inflexible patterns of behaviour and interests,[6, 7]. Presentation varies significantly in relation to 
severity of these deficits, intellectual ability or disability and language skills,[6, 7]. Co-occurring  mental 
health conditions are common,[1] and children with autism, whether with associated learning 
difficulties or not, contribute significantly to in-patient Tier 4 Child and Adolescent Mental Health 
Services (CAMHS), particularly in girls without learning disability, often only receiving a diagnosis once 
in that setting,[8].  
People with autism are often dependent on adult support and/or care throughout their lives. The costs 
associated with autism include financial costs to families and education, supportive living 
accommodation and individual productivity loss,[9]. The impact of autism and behavioural difficulties 
on families is great, with parents of children with autism experiencing higher levels of stress than 
parents of children with other disabilities,[10].  
Services for children and young people with autism are under increasing pressure to deliver timely 
diagnostic assessment. The National Autism Plan for Children in 2003,[11] recommended that the first 
professional contact with parents following referral to Child Development Services (CDCs) or CAMHS 
should be within six weeks of referral, and that the assessment process should be completed with 13 
weeks. However, journey times from referral to diagnosis as long as 799 days have been reported,[12, 
13, 14] and a recent service review highlighted the frustration of families, ‘sometimes isolated, with 
little or no support’,[13].  This suggests demand for diagnostic services has outstripped capacity, 
exacerbated by recent increases in demand,[15]. Additionally, assessment is time consuming and 
costly; Galliver et al,[16] found assessments took a mean of 13 hours of professional time, costing 
£800 per child/young person. Our recent study of 500 children’s diagnostic journeys estimated 15 
hours, costing around £950 per child,[14].  
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Beyond the issues of capacity, there are several factors relating to the child, their family or the 
professionals involved which contribute to the time taken in reaching a diagnosis,[14]. Brett et al,[17] 
identified the importance of case complexity, with the presence of additional neurodevelopmental 
diagnoses such as attention deficit hyperactivity disorder (ADHD),[18] delaying diagnosis. The longest 
journey times reflect either complexity, adoption of a ‘wait and see’ approach, or family issues such 
as poor clinic attendance,[19]. Other family factors including socio-economic status and the presence 
of a pre-existing sibling with autism in the family may reduce time to diagnosis,[17]. 
There is wide variation between services in the pathway to diagnosis. UK NHS diagnostic practice is 
based on National Institute for Heath and Care Excellence (NICE) guidelines,[20], widely acknowledged 
as a gold standard internationally. Diagnosis requires assessment of the child in more than one setting, 
for example home, school and clinic. NICE,[20] recommends using a multidisciplinary team (MDT) 
approach with representation from child health and mental health services, with a core team of a 
paediatrician and/or child and adolescent psychiatrist, speech therapist and psychologist. Assessment 
should consider a range of explanations for individual signs and symptoms, including other 
neurodevelopmental disorders, mental health and behavioural disorders,[20]. To achieve this is labour 
intensive and often costly,[21] but identifies essential areas of health and support needs for the child 
and family.  
Several services have already adapted their pathways in an attempt to become timelier and more 
efficient. Approaches include single practitioner or abbreviated assessments,[15, 22, 23], both 
reducing the hours of professional time involved,[23]; the use of skill mix, for example replacing 
expensive doctor time with a nurse or allied health professional specialist role; training programmes 
to increase the expertise and competencies of team members and referrers; and improving 
information gathering either prior to accepting the referral,[15] or through the use of digital 
technologies,[24]. However, the MDT approach remains the gold standard, is necessary in most cases 
to manage diagnostic complexity, and to create a complete picture of the child/young person’s 
strengths and needs,[20]. There are also examples of services that have benefited from overall 
structural reorganisation, for example by integration of CDCs and CAMHS,[25]; joining diagnostic 
services together,[15]; and improving data collection,[15]. Integrating diagnostic services for autism 
and ADHD, which frequently co-occur, could possibly improve efficiency by avoiding children going 
through separate but very similar diagnostic processes for each possible condition,[25].  
Families frequently report negative experiences of the journey through the diagnostic assessment 
process, alongside lack of signposting and access to support and therapeutic intervention,[26, 27] 
post-diagnosis. Crane et al,[26]’s survey of 1047 families who had been through an autism diagnostic 
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process in the UK, found over 50% were dissatisfied with the process. Predictors for low satisfaction 
included time taken to diagnosis, quality of information given, stress associated with the diagnostic 
process and quality of support offered post-diagnosis.  
The need to improve the diagnostic process and support for families for children with possible autism 
has been widely acknowledged,[1, 15, 26, 27]. However, there is a significant evidence gap concerning 
how best to deliver effective and efficient diagnostic pathways for children and young people with 
possible autism in a timely manner and how to deliver appropriate support to families throughout the 
diagnostic process. This paper represents the protocol for a seven-month rapid realist review, as part 
of the RE-ASCeD research programme, commencing Jan 2020 and intending to fill this evidence gap. 
Aims and objectives 
Given that some local providers have already reconfigured their services in an attempt to address 
these issues,[15, 28], this Rapid Realist Review (RRR) is the first step in a national Realist Evaluation of 
Autism ServiCe Delivery (RE-ASCeD). This review aims to explore how particular approaches may 
deliver high quality and timely autism diagnostic services for children with possible autism; high 
quality is defined as compliant with NICE (2011) guidelines,[20] and timely is defined as a pathway 
lasting no more than one calendar year, based on previous work (paper in preparation). Research 
questions for the RRR are as follows: 
1. How do various models of autism diagnostic and support services address the differing needs 
of different service user groups and what contexts and mechanisms affect their ability to do 
so? 
2. How do models of autism diagnostic and support services improve service user diagnostic 
experience? 
3. What aspects of implementation, staffing and organisational context influence how models 
of autism diagnostic and support services operate? 
METHODS AND ANALYSIS 
In line with a realist approach, we will conduct an RRR to build on the systematic review undertaken 
in preparation for the NICE guidelines,[20]. The RRR will add to this through providing context-specific 
explanations for what works within a particular set of parameters,[29]. RRR is a well-established 
approach to synthesising evidence within a compressed time period that can identify groups of 
interventions or models of service delivery that relate to desired outcomes,[29]. In using an RRR 
approach we will work backwards from the intended outcomes as identified by NICE guidelines,[20] 
and the NHS England Long-Term Plan,[1]. The key steps are consistent with the RAMESES 
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standards,[30] for realist syntheses and include identifying the research question, searching for 
information, quality appraisal, data extraction, synthesising the evidence, validation of findings with 
content experts, and dissemination,[29, 31].  
What differentiates RRR from a full realist review is arguable but RRR is explicitly designed to engage 
those with expertise in order accelerate the search process and validate findings,[29]. The wider RE-
ASCeD project team have significant expertise in realist evaluation, paediatric neurodisability and 
autism and their contribution to each stage is outlined below. The Expert Stakeholder Group consists 
of content experts, knowledge users and policy makers with a wide range of experience, including 
consultant paediatrician, speech and language therapy, child psychology, occupational therapy, third 
sector advocacy groups and patient and public involvement (PPI). However, stakeholder involvement 
does not replace the literature search but serves to supplement, tailor and expedite it,[29, 32].  
Our focus is a clearly defined intervention (the diagnostic pathway), associated with specific outcomes 
(high quality and timely) within a particular set of parameters (autism/CAMHS services in the UK); this 
is consistent with a realist focus on ‘theory-driven, contextually relevant interventions that are likely 
to be associated with specific outcomes within a particular set of parameters’,[29 p3]. Our initial 
Programme Theory, based on NICE (2011) guidance, the project team and Expert Stakeholder Group, 
states:  
If there is a MDT assessment by a team with competencies in child neurodevelopment and 
mental health (context), then Autism will be recognised as a complex condition that relies on 
detailed history and observation across settings (mechanism) to diagnose it. This will lead to 
accurate diagnosis, recognition of associated co-occurring conditions such as ADHD and 
intellectual disability (outcome), and the ruling out of complex differential diagnoses. This will 
also create, whilst not an explicit part of this project, an accurate picture of a child’s strengths 
and needs to inform individualised packages of support and intervention through health, 
education and social care (outcome). 
We will follow the five stages of RRR,[29], including developing and refining the scope of the review; 
searching and identifying information; extracting and appraising the evidence; synthesizing and 
interpreting the evidence; validation with expert stakeholders and dissemination (Figure 1). 
Preliminary explanations will then be tested within later stages of the whole project.  Table 1 provides 
a summary of realist terms. 
 [Insert Figure 1] 
 
Table 1: Realist terminology 
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Term Explanation [33, 34] 
Context Refers to the ‘backdrop’ of interventions (in this case the diagnostic 
pathway), or anything outside the parameters of the intervention that 
might affect it, for example, shortages of community paediatricians. 
Context can also be understood as ‘any condition that triggers and/or 
modifies the mechanism’,[34]. 
Mechanism The generative force that leads to an outcome of interest; usually 
hidden and context-sensitive. Mechanisms consist of intervention 
resources and how people respond to them. 
Outcome The outcome, intended or unintended, of a complex intervention such 
as timely assessment of possible autism in children. Outcomes can be 
initial, intermediate or final. 
CMO configuration(s) CMO configuring is a heuristic used to general causative explanations 
relating to outcomes. The process explores the relationship between an 
outcome of interest in a particular context; and the underlying 
mechanism. CMO configurations are a way of refining theory about 
aspects of the intervention, or the intervention overall. 
Programme theory This is the overarching theory of how a particular complex intervention 
may work; it draws on evidence, data and creative (retroductive) 
thinking to seek explanations of how, why and in what contexts an 
intervention works. The initial programme theory is tested and refined 
in an iterative process throughout the RRR.  
Programme areas These are areas, or themes, within the overarching theory, for example, 
GP involvement in the autism referral pathway. 
Middle range theory 
(MRT) 
An explanatory theory that can be used to explain a complex 
intervention, or aspects of it. While CMO configurations are specific to 
the intervention under investigation, and underpin the programme 
theory, MRTs are more generic and have wider application. 
 
Stage 1: developing and refining the research question (Sep 19-Jan 20) 
[Insert Figure 2] 
The first stage aims to confirm and refine the research question and scope, and prioritise areas for 
investigation (Figure 2). This stage is in progress through ongoing discussions with our Chief 
Investigator (IM, Consultant community paediatrician), Co-investigators, NHS England and our Expert 
Stakeholder Group.  
The RRR team (the core researchers working on the RRR within the larger project team) has carried 
out preliminary work for Stage 1, as follows: 
 An initial pre-protocol literature search informed by clinical experience (IM) 
 Discussion within the RE-ASCeD project team to define the scope and remit of review  
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 Training on the diagnostic pathway for the research assistants (RAs) (VA, WZ) by a consultant 
neuro-developmental paediatrician, also a Co-investigator. 
 Expert Stakeholder Group workshop to help confirm and refine the research questions, 
inclusion and exclusion criteria (Table 2), and identify salient documents (policy and grey 
literature) for review,[32]. Telephone discussions were carried out with expert stakeholders 
who were unable to attend the workshop. 
Stage 1 activities will function as a starting point to develop initial programme areas which will be 
discussed with the Expert Stakeholder Group before moving to stage 2.  
Stage 2: searching and retrieving information (Jan-Feb 20) 
 [Insert Figure 3] 
Stage 2 will start with screening information from the background search carried out in Stage 1, which 
we anticipate will include national policy/guidelines and grey literature on local implementation of 
the diagnostic pathway (Figure 3). Two experienced RAs (VA, WZ) will conduct the pilot screening 
initially by title and abstract, and then with full text for those deemed relevant. The pilot screening 
will help further develop the abstract screening tool (Table 3) co-produced by the RRR team and expert 
stakeholders in Stage 1. 
Table 2: Inclusion/exclusion criteria 
Primary inclusion criteria: 
1. Children (preschool, primary or secondary school and adolescents) with Autism Spectrum 
Disorder OR Autism spectrum condition AND 
2. UK health care system (England, Scotland, Wales and/or N. Ireland) AND 
3. Published 2011 onwards AND 
4. Relates to diagnostic pathway & model of service provision OR 
5. Relates to assessment process e.g. single discipline (paediatric consultant) or inter-
disciplinary  
Primary exclusion criteria: 
1. Non-UK based literature 
2. Relates only to adult diagnostic pathway 
3. Relates only to tertiary services 
4. Only relates to treatment  
5. Relates to support services only after diagnosis. 
 






Primary focus is on diagnostic pathway whether the model is autism specific, 
autism/CAMHS, integrated neuro-developmental pathway;  AND 
Relates to certain aspects of diagnostic pathway e.g. skills mix OR 
Comments on implementation issues &/or contextual issues &/or outcomes OR 
Relates to quality or timeliness or cost-effectiveness of diagnostic pathway OR 
Relates to service user experience OR 
Relates to support services up to diagnosis OR 




Some description of diagnostic pathway but not the main focus 
Little information on implementation, context or outcomes  
Limited reference to quality, timeliness or cost-effectiveness of diagnostic 
pathway  
Briefly refers to service user experience  
Briefly refers to support services up to (and/or post-) diagnosis  
Explores stakeholder perspective (commissioners, clinicians, other) up to (and/or 
post-) diagnosis 
Mostly not relevant but contains some ‘nuggets’  
Not relevant Does not meet above criteria e.g. only focuses on post-diagnosis or adults 
 
The search carried out by the information technologist will be performed in three stages,[35]. Firstly, 
iterative pilot searches will be carried out in Medline to refine the search strategy. The pilot searches 
will use a combination of text terms and synonyms appearing in the title, abstract and keywords in 
combination with index terms (MeSH subject headings) using the OR operator. These concepts will 
then be combined using the AND operator. By checking synonyms and further exploring MeSH index 
terms, the search can be tailored to ensure relevant papers are retrieved. The strategy will be modified 
to increase the sensitivity of the search by excluding some terms, including others, trialling MeSH 
terms, or dropping the keyword field and restricting to the abstract and title fields only. Limits are 
papers written in English and published after 2011, when the NICE guidelines for recognition, referral 
& diagnosis of autism in under 19s was published,[20]. The search will be restricted to UK only, given 
specific NHS context, but if insufficient evidence is identified, a secondary search will include 
comparable countries (e.g. USA, Canada, Australia, New Zealand) albeit with different healthcare 
systems.  
Secondly, the primary search for empirical evidence will be used to identify published studies and 
evaluations of autism diagnostic and support services. It will search databases including Medline 
(Ovid), Embase (Ovid), PsycINFO (Ovid), Social Policy & Practice (Ovid), CINAHL Plus (EBSCO), Cochrane 
Library and Web of Science (Clarivate) with limits of dates (2011-current), language (English) and 
country (UK only). Each database varies with different index terms (or none) and searchable fields 
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which means the strategy will be amended for each database. We will include studies of any design 
including randomised controlled trials, controlled studies, effectiveness studies, uncontrolled studies, 
interrupted time series studies (ITS), cost-effectiveness studies, process evaluations and qualitative 
studies. To understand the complexities of the autism diagnostic pathway, we will take account of 
literature reporting all stakeholder perspectives including those of children/adolescents, parents, 
clinicians, service managers and commissioners.  
Primary search results will be screened and retrieved by the RAs (VA and WZ), initially by title and 
abstract using the abstract screening tool (Table 2) to identify articles as highly, probably or not 
relevant. All ‘probably relevant’ articles will be reviewed by both RAs; where undecided, one Co-
investigators (PW) will decide. Full text will be retrieved for all papers deemed relevant (Figure 4). 
Endnote will be used to store and categorise the search results by the three relevance categories.  
 [Insert Figure 4] 
Lastly, secondary searching will be conducted iteratively throughout the review with input from our 
Expert Stakeholder Group. The two RAs will use papers identified in the primary and background 
search to look through reference lists for relevant articles; check forward citations; and search key 
authors and research teams to identify further literature, using Google scholar. The RAs will screen 
the secondary search results and relevant papers will be included. Prior to data extraction, our expert 
stakeholders will be consulted to ensure that all key literature is included; this step will be repeated 
at the consolidation workshop (Stage 5).  
Stage 3: extracting and appraising the evidence (Feb-Mar 20) 
Within evidence analysis involves data extraction and appraisal of individual papers based on 
relevance and rigour. Data extraction will be carried out using a hybrid approach,[36]. First, basic 
details from each article will be recorded in a data extraction form in Excel; the tool will include 
information about the diagnostic pathway, service delivery characteristics, and any evidence related 
to intended (or unintended) outcomes,[35]. Secondary exclusion criteria will be developed to 
eliminate articles that do not contribute to the overall programme theory. Second, included articles 
will be imported into Nvivo under ‘sources’; the coding framework will have one node for each 
programme area (for example, the skills mix of the diagnostic team) and sub-nodes will be created as 
appropriate. The RAs will code relevant extracts of each paper, using annotation and note-taking to 
record comments related to context, outcomes and possible mechanisms,[36]. Annotations and note-
taking will serve as an audit trail and a record of our decision-making processes and rationales for 
developing our programme theories,[37]. 
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For both stages of data extraction and analysis, the two RAs will review three papers jointly and three 
independently and then compare findings; the remaining papers will be split and reviewed 
independently by one RA. For twenty percent of papers, a series of calibration exercises will be 
undertaken by the RRR Lead (PW). 
Appraisal of evidence will be based on the concepts of relevance, rigour and richness,[33, 38]. 
Relevance refers to whether the evidence can contribute to theory building and/or testing; evidence 
can be highly relevant but not necessarily trustworthy. Rigour questions whether the methods used 
to generate the data are trustworthy and credible (or plausible); this includes ‘nuggets of wisdom’,[39 
p127] in otherwise methodologically weak studies. Alongside quality, evidence will be appraised in 
terms of how credible, or coherent, it is which involves examining the reasoning behind the argument 
and considering the coherence of the programme theory developed from the data,[30]. Richness 
refers to the existence and quality of causal insights and encompasses rich descriptions of context, 
process or outcomes,[33]  
When the RAs are uncertain about the extraction or appraisal of a paper, this will be discussed with 
the RRR Lead (PW).  
Stage 4: synthesising information (Mar-May 20) 
Our ‘hybrid’ approach to data extraction in Stage 3 will aid the process of distilling context and 
outcomes thereby allowing identification of underlying mechanisms within each programme area. The 
aim is to make sense of our initial and evolving programme theory. Evidence synthesis will use 
interpretative cross-evidence comparison to interrogate the data: we will move iteratively between 
analysing specific examples (i.e. extracts from one study); comparing and contrasting findings from 
different studies whilst also considering their respective methodological strengths and weaknesses; 
further searching to interrogate, confirm or refute CMO configurations; and refining the overall 
programme theory,[36, 40]. This retroductive process of exploring observable patterns to discover 
underlying mechanisms will involve the whole RRR team to ensure validity and consistency of theory 
building [38]; we will also consult with expert stakeholders iteratively. Cross-evidence analysis will 
allow us to develop and refine CMO configurations, which we will align with our research questions 
to build or search for existing explanatory middle range theories (MRT). At a practical level, we will 
continue to use annotations and linked memos in Nvivo to maintain transparency and capture 
decision-making but will also use simple tables in a Word document, one per programme area, to 
capture (multiple) CMO configurations which will be linked back to the evidence, with commentary 
on possible MRTs (either existing MRTs and/or evolving ones).  
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Stage 5: interpreting and refining (May-Jun 20) 
We will run a data interpretation workshop with our Expert Stakeholder Group to test and refine CMO 
configurations, which will further contribute to the refinement of our final programme theories and 
MRTs. Our Expert Stakeholders will also be asked to suggest any additional literature which helps 
elucidate the programme theories. Framed by the RRR approach, our final report will highlight service 
models that in certain contexts will trigger specific mechanisms that lead to outcomes of interest,[29]. 
 
Patient and public involvement 
Engaging PPI representatives from the start, as part of our Expert Stakeholders Group, has enabled us 
to focus the review on questions that stakeholders are most interested in answering and will enable 
identification of salient documents for review, many of which are grey literature or unpublished,[32]. 
PPI involvement is integral to the overall project, has been embedded into the review protocol and 
will be particularly helpful when synthesising and interpreting the data (Stage 5).  
Limitations 
We are explicitly setting pragmatic limits on the literature search (Stage 1-2) as RRR allows,[29] and 
acknowledge that it cannot be as extensive as a full realist review, given an externally imposed time 
limit. We are mindful of comprehensiveness without accruing too much extraneous material in the 
process. Engaging with our stakeholders throughout the process will enable an iterative approach to 
identifying relevant literature. The search is limited to UK literature because this is pertinent to our 
research questions but we acknowledge that we may miss literature from other similar health systems 
that could inform our programme theories. We are also limiting the secondary search in that we 
intend to do forward citations for key papers and authors only. However, while we have set limits on 
the literature search, the synthesis (Stages 3-5) is as extensive as that for a full realist review.  
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FIGURE LEGENDS:  
Figure 1. RE-ASCeD rapid realist review stages 
Figure 2. Developing and refining the research question 
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Stage 1: Develop and refine the research question 
Confirm & refine research question & review scope: 
project meetings, training, Expert Stakeholder Group 
workshop and further discussions. 
Search for & develop initial programme theories. 
Background search & refine in/exclusion criteria 
Stage 2: Search and retrieve information 
Pilot screening of grey literature to refine 
in/exclusion criteria and test abstract 
screening tool;  
Searches include pilot search, primary search, 
and iterative secondary searches. 
Selected articles screened & retrieved.  
Stage 3: Extract and appraise the evidence 
Within evidence analysis: data extraction and appraisal of 
individual papers, based on relevance and rigour: 
- Data extraction form in Excel; secondary exclusion 
criteria will be developed to eliminate any articles that 
do not contribute to the programme theories.  
- Annotation and note-taking of selected papers to CMO 
configurations will be carried out in NVivo, guided by the 
initial programme theories.  
 
 
Stage 4: Synthesis 
information 
Interpretative cross-evidence 
comparison to build programme 
theories & develop middle-range 
theories; confirm/refute & refine 
CMO configurations. 
Consult expert stakeholders 
  
Stage 5: Interpret and 
refine 
Data interpretation workshop 
to test and refine CMO 














Figure 2. Developing and refining the research question 
Refine research question (RQ) & the scope of the review: 
- Initial meetings Co-investigators, information specialist & RAs 
- Pre-protocol literature search informed by clinical experience  
- Training by consultant neuro-development paediatrician on 
diagnostic pathway for RAs 
- Expert Stakeholder Group workshop 
- Snowball sampling for further discussions with expert 
stakeholders 
Background search: grey literature, policy & 
guidelines from content experts 
 
Refine in/exclusion criteria (Table 2)  






Figure 3. Searching and retrieving information  
Primary search for empirical evidence: 
identify published studies and evaluations of 
autism diagnostic and support services. 
Secondary search: conducted 
iteratively throughout, using 
papers identified in primary 
search to: 
• Search reference lists  
 Check forward citations 
• Google scholar search key 
authors & research teams to 
identify grey literature. 
 
Pilot screening to test & refine in/exclusion criteria (Table 2) & 
abstract screening tool (Table 3). 
Background search of grey lit from 
Stage 1 
Identification/retrieval: papers will be screened by title 
and abstract using the abstract screening tool (Table 3) & 
categorised as highly, probably or not relevant (Figure 4). 
Pilot searches: iterative process in Medline to 















Review by 2 RAs & 
consult RRR Lead 
Relevant Retrieve 
full text 
Not 
relevant 
Papers 
identified 
from the 
primary 
search 
